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Degradation of albumin by the renal proximal tubule cells and
the subsequent fate of its fragments.
Background. In view of recent reports of large amounts
of albumin fragments present in normal urine we investi-
gated the mechanism of albumin handling by the proximal
tubule.
Methods. We injected 125I-albumin intravenously in rats and
measured the excretion of intact and degraded 125I-albumin in
the urine by trichloroacetic acid (TCA) precipitation. The ex-
cretion rate of intact 125I-albumin was compared to that ob-
tained by routine radioimmunoassay (RIA). Human proximal
tubular HK-2 cells were used to characterize the albumin recep-
tor and study the degradation of albumin to peptides, establish
their size by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and gel filtration chromatography,
and determine the direction in which the degradation products
are removed from the cell.
Results. Following injection of 125I-albumin intravenously
into rats we recovered large quantities of 125I-albumin frag-
ments in urine and determined that 98% was in a highly de-
graded form and only 2% was intact. Only the intact albumin
could be detected by RIA. We observed similar results in the
urine of ex vivo kidneys perfused with 125I-albumin. We found
that 125I-albumin was taken up by HK-2 cells via a receptor,
degraded in the lysosomes and the peptides exocytosed to both
the apical and basolateral sides of the cells.
Conclusion. We conclude that normally the kidney degrades
large amounts of albumin and that the degradation fragments
appear in the urine. These findings are in sharp contrast with
the established view that degraded albumin is completely reab-
sorbed into the blood stream.
In health, small quantities of intact albumin appear in
the urine. According to the generally accepted theory, the
albumin present in the lumen of the proximal tubule is
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largely reabsorbed, then degraded into amino acids by
the proximal tubule and reutilized by the body [1, 2].
The albumin not taken up by the proximal tubule ap-
pears in the urine. It is uncertain, however, how much
albumin passes through the glomerular filter and is pro-
cessed by the proximal tubule, because measurements
of albumin concentrations in glomerular fluid samples
using the micropuncture technique have yielded vari-
able results [3, 4]. Thus, despite the lack of a consensus
as to how much albumin is processed by the proximal
tubule, it is widely believed that most filtered albumin
is salvaged after complete degradation by the proximal
tubule.
The above concept of renal handling of albumin was
derived from experiments in microdissected segments of
the proximal tubule of the rabbit perfused with albumin
solutions [5]. In these studies it was shown that low con-
centrations of albumin in the perfusate were taken up and
completely degraded by the proximal tubule, and that the
degradation products were entirely released into the ba-
solateral side. No degradation products were detected in
the apical side, suggesting that albumin fragments would
not be present in the final urine.
Recently, Osicka et al [6, 7] have shown that fol-
lowing the injection of tritium-labeled albumin, large
amounts of albumin-derived fragments were excreted in
normal rat and human urine, thus challenging the ex-
isting theory. However, the experimental design used
in these studies did not allow an accurate measure-
ment of the proportion of the albumin fragments that
was excreted in the urine and that reabsorbed in the
blood.
As the conclusions derived from these two studies are
incompatible with each other, we have attempted to re-
solve this issue by experiments in vivo and ex vivo kid-
ney preparations. We have further shed some light on the
mechanism of albumin handling by quantifying the apical
and basal excretion of albumin degradation products in
the cultured proximal tubule cell.
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METHODS
Labeling of albumin with radioactive iodine
and fluoroscein
Serum albumin (rat or human) (Sigma Chemical Co.
St Louis, MO, USA) was labeled with either radioac-
tive iodine (125I) or fluoroscein. For radiolabeling,
Chloramine-T method was used [8]. The label was typ-
ically >98% protein bound and its specific activity was
∼4000 to 6000 cpm/ng. Fluoroscein labeling was done by
mixing albumin solution with a 10 mol/L excess solution
of fluoroscein isothiocyanate (FITC) (Sigma Chemical
Co.) at pH 7.4. The FITC was dissolved in 95% ethanol
and added dropwise to the albumin solution. The volume
of the FITC solution never exceeded 5% of the volume
of the albumin solution. The mixture was wrapped in alu-
minum foil to protect from light and incubated at room
temperature overnight. The mixture was dialyzed exten-
sively for two days at 4◦C with phosphate (10 mmol/L)-
buffered saline (125 mmol/L) (PBS), pH 7.4, to remove
unreacted fluoroscein. Fluorescence measurement of the
FITC-albumin conjugate at Ex490/Em520 showed that the
molar ratio of FITC: albumin in the conjugate was 1:1.
Injection of 125I-albumin to rats
Male Sprague-Dawley rats (300 to 350 g) (Harlan Lab-
oratories, Indianapolis, IN, USA) were injected intra-
venously with 1 lg of 125I-rat albumin in 0.2 mL of saline.
A sample of blood was collected within 15 minutes for
initial 125I-albumin determination. The rats were placed
in metabolic cages for 3 hours for urine collection. At
the end of the 3-hour urine collection, the rats were
anesthetized and a sample of blood was collected for
the final determination of 125I-albumin. Urine and blood
were analyzed for intact and degraded 125I-albumin by
trichloroacetic acid (TCA) precipitation analysis.
TCA precipitation for separation of intact and
degraded 125I-albumin
Urine (or media) samples were precipitated with 10%
TCA, the mixture incubated for 30 minutes on ice and
then centrifuged for 15 minutes at 10,000g to separate
the intact 125I-albumin (TCA pellet) and degraded 125I-
albumin (TCA supernatant). The two fractions were
counted in a gamma counter (Packard, Downer’s Grove,
IL, USA).
To characterize the size of 125I-albumin peptides that
precipitate with 10% TCA, urine samples (N = 6) were
analyzed by two ways: (1) urines were chromatographed
in a Biogel P-60 gel filtration column (see below) and
the various fractions were subjected to 10% TCA precip-
itation, and (2) the unfractionated urine samples were
precipitated by 10% TCA, and the pellet and soluble
fractions were separately chromatographed to see which
fragments were precipitated and which were not.
Excretion rates of intact and total (intact + degraded)
125I-albumin in urine
The excretion rate of albumin was determined from the
125I- radioactivity counts (counts per minute) as follows:
Initial blood cpm/mL (15 minutes) + final blood cpm/mL
(3 hours) was divided by 2 to obtain the mean cpm/mL
in blood during the 3-hour collection period. This num-
ber was divided by the albumin concentration in blood
(55,000 lg/mL) as determined by the albumin blue
method described before [9] to obtain the specific activity
of 125I-albumin in blood in terms of cpm/lg albumin. The
excretion rate of albumin [intact or total (intact + de-
graded)] in lg/min was calculated as cpm in urine (intact
or total)/180 min/specific activity of 125I-albumin in blood.
Note that the 125I-albumin in the final blood sample (after
3 hours of injection) was approximately 5% less than in
the initial blood sample obtained at 15 minutes indicating
that the 125I-albumin level in blood was stable over this
period. Also, both samples had a TCA precipitability of
>99%, showing negligible degradation of 125I-albumin in
the blood.
Radioimmunoassay (RIA) for rat albumin
A competitive RIA for rat albumin was set up using
radiolabeled (125I) rat albumin and rabbit antirat albu-
min antibody (Sigma Chemical Co.) mixed with samples
or standards (100 ng/mL to 10 lg/mL) as described pre-
viously for human albumin [10]. After overnight incu-
bation at 4◦C the immune complexes were precipitated
with protein A containing Staphyloccocus aureus (Sigma
Chemical Co.) and the precipitates counted in a gamma
counter.
Ex vivo perfusion of kidneys with 125I-albumin
Rats were anesthetized with 50 mg/kg sodium pento-
barbital by intraperitoneal injection and prepared for ex
vivo perfusion of isolated kidneys [11]. A longitudinal
mid-abdominal incision was made to expose both ureters
that were cannulated with PE-10 tubing (Intramedic,
Clay Adams, Sparks, MD, USA). The renal vascular bed
was isolated by ligation of the mesenteric vessels and the
aorta proximal to the renal arteries. A cannula was placed
at the descending aorta below the renal artery and se-
cured by a ligature. An incision was made in the infe-
rior vena cava to allow the outflow. The kidneys were
initially flushed with PBS at 37◦C to remove blood. The
kidneys were then perfused with 50 mL of prewarmed
(37◦C) PBS containing 1 lg of 125I-albumin over 10 min-
utes. The kidneys were perfused for another 4 minutes
with 20 mL of prewarmed PBS. Urine was collected
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during the 14-minute perfusion period and saved at
−20◦C until analysis.
In another group of animals where the effect of chloro-
quine was tested, chloroquine (10 lmol/L) (Sigma Chem-
ical Co.) was added to the perfusate.
Culture of human proximal tubular cells (HK-2)
The human proximal tubular cell line (HK-2) was
originally derived from normal adult human renal cor-
tex by hybridization with the retrovirus human pa-
pilloma virus 16 E6/E7 genes [12]. They grow in
a monolayer forming domes suggestive of a polar
cell. These cells are epidermal growth factor (EGF)-
dependent and stain positive for alkaline phosphatase,
gamma glutamyltranspeptidase, leucine aminopeptidase,
acid phosphatase, cytokeratin, a3b 1 integrin, and fi-
bronectin and negative for factor VIII. They have a
functioning sodium-dependent/phlorizin-sensitive sugar
transport and sodium bicarbonate co-transporter. They
have been shown to have parathyroid hormone (PTH)-
sensitive and antidiruetic hormone (ADH)-insensitive
adenylate cyclase.
The cells were maintained in Dulbecco’s modified Ea-
gle’s medium (DMEM) (low glucose) and F-12 Ham
(low glucose) media mixed in a 1:1 ratio (Gibco, Life
Technologies, Rockville, MD, USA) with added HEPES
(20 mmol/L), antibiotics, and 5% fetal bovine serum
(FBS). For experiments the cell cultures were grown to
confluence.
Binding and uptake of albumin by HK-2 cells
Medium from confluent layers of cells was replaced
with fresh basal medium without serum. To the medium
was added 125I-albumin (or FITC-albumin) and the cells
were incubated either at 4◦C for 2 hours (for bind-
ing experiments) or at 37◦C in 5% CO2-95% air for 1
to 6 hours for endocytosis experiments. For inhibition
experiments the incubation media also included unla-
beled albumin. For binding experiments, media was dis-
carded after the incubation period, the cell layer washed
extensively with cold PBS, extracted in 0.1% sodium
dodecyl sulfate (SDS), and gamma counted. For endocy-
tosis experiments, following incubation with 125I-albumin
(or FITC-albumin) the media was discarded and the cell
layer washed with fresh media containing 10 mg/mL of
unlabeled albumin to remove the membrane bound 125I-
albumin (or FITC-albumin) and the cells further incu-
bated at 37◦C for 18 hours. Then the media was collected
and the cell layers were washed extensively with cold PBS
and extracted in 0.1% SDS for measurement of degraded
125I-albumin. Experiments with FITC-albumin were per-
formed on cells grown on LabTek chamber slides (Nunc,
Naperville, IL, USA) to allow microscopic examination
and photography of the cell layers. Cells incubated with
FITC-albumin were washed with cold PBS and examined
under an epifluorescent light microscope (Nikon, New
York, NY, USA).
Analyses of cell media and cell extracts
for degraded albumin
Media and cell extracts were analyzed for the measure-
ment of degraded 125I-albumin by (1) precipitation with
10% TCA, (2) SDS-polyacrylamide gel electrophoresis
(PAGE) followed by autoradiography, and (3) gel filtra-
tion chromatography using a Biogel P-60 column (Bio-
Rad Laboratories, Richmond, CA, USA).
Culture of HK-2 cells on Millicell filter dishes
to study excretion of degraded 125I-albumin products
to apical and basal media
HK-2 cells were seeded on Millicell filter dishes
(Millipore, MA, USA) which permit access to both
the apical and basal fluid compartments of the cell
[13]. After the cells reached confluency cells were in-
cubated with 125I-albumin (on the apical side) to reach
steady-state levels (>4 hours) after which membrane-
bound albumin was washed away with excess unla-
beled albumin and cells were then allowed to process
the internalized 125I-albumin at 37◦C for 18 hours.
The media from the apical and basal compartments
were collected and analyzed for intact and fragmented
125I-albumin by TCA analysis. In preliminary experi-
ments, we determined the leakage of the monolayer by
pulsing the apical media with tritium [3H]-labeled inulin
and found that the confluent monolayer only allowed 4%
of the inulin to cross the monolayer and appear in the
basal media in 24 hours.
RESULTS
TCA precipitation analysis
These studies were performed to characterize the al-
bumin fragments precipitated by TCA. Figure 1A shows
a typical gel filtration chromatogram of rat urine col-
lected after injection of 125I-albumin. It contained intact
125I-albumin and fragments in the range of <5 to 66 kD
with two major peaks of intact (and large fragments)
(60 to 66 kD) and small fragments (5 to 14 kD). The
precipitability of the fragments by 10% TCA decreased
from 98% for the intact albumin to 5% for the small-
est fragments (Fig. 1B). Chromatographic analysis of the
TCA pellet and the TCA soluble fractions of unfraction-
ated urine confirmed these findings. While the TCA sol-
uble fraction predominantly contained the <14 kD sized
peptides, the TCA precipitate contained all the higher
fragments (Fig. 1C and D). Based on these data the TCA
soluble fraction of rat urine in our experiments will mostly
represent <14 kD fragments of albumin.
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Fig. 1. Gel filtration chromatography of rat
urine containing 125I-albumin and fragments,
precipitation of different fractions by 10%
trichloroacetic acid (TCA), and chromatog-
raphy of TCA soluble and precipitate frac-
tions of rat urine. (A) Rat urine contained in-
tact 125I-albumin and fragments in the range
of <5 to 66 kD with two major peaks of in-
tact (and large fragments, 60 to 66 kD) and
small fragments (5 to 14 kD). (B) Ten percent
TCA precipitated 98% of the intact albumin,
lesser proportions of albumin fragments and
only 5% of the smallest fragments. (C) Chro-
matographic analysis of the TCA pellet and
TCA soluble fractions of unfractionated urine
showed that while the TCA soluble fraction
predominantly contained the <14 kD sized
peptides, the TCA precipitate contained all
the higher fragments.
Comparison of albumin excretion rates by RIA
and by measurement of intact and fragmented
125I-albumin in the urine
The albumin excretion rate in the rat was determined
by the conventional method of measuring albumin by
RIA that measures only intact albumin and compared
to that obtained by measuring the excretion rate of 125I-
albumin after systemic injection of 125I-albumin (Table 1).
The mean albumin excretion rate as determined by RIA
was 4.8 lg/min. Excretion rate of injected 125I-albumin
was expressed in terms of excretion rate of intact 125I-
albumin and excretion rate of total (intact + degraded)
125I-albumin based on the TCA precipitation analysis.
The excretion rate of intact urinary 125I-albumin was
6.1 lg/min—a value close to that obtained by RIA.
If we consider the total 125I-radioactivity excreted in
the urine (intact 125I-albumin + degraded products of
125I-albumin) the excretion rate was 70 times higher
(349.6 lg/min), suggesting that >98% of total albumin
present in the urine was degraded and that the degraded
albumin was not detected by the RIA. Expressed in a
standard manner, this excretion rate of albumin trans-
lated to 6.5 mg/100 g body weight/hour (considering the
average weight of the rats to be 325 g).
Size of peptides derived from the degradation
of 125I-albumin in the urine
Rat urine samples (N = 4) collected after the sys-
temic injection of 125I-albumin were also fractionated
by gel filtration chromatography to quantitate the frag-
ments (Table 2) (Fig. 1A shows a representative chro-
matogram). 125I-radioactivity was determined in fractions
corresponding to molecular sizes of >60 kD, 14 to 60 kD,
and 5 to 14 kD. We found that while only 4.5% of the
125I-albumin in the urine was of high molecular weight
(>60 kD), 29.5% of the activity was in albumin-derived
peptides of intermediate size (14 to 60 kD), 65.9% in
small peptides (5 to 14 kD), and 0.1% in small molecules,
including amino acids and free 125I-iodine. These results
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Table 1. Comparison of albumin excretion rates in the rat by radioimmunoassay (RIA) and by measurement of radioactive 125I-albumin in urine
after systemic injection of 125I-albumin
Excretion rate of
Excretion rate of Excretion rate of total 125I-albumin Percent 125I-albumin
albumin by RIA intact 125I-albumin (intact and degraded) degraded in urine
lg/min lg/min lg/min (degraded/intact + degraded)
Mean ± SE (N = 10) 4.8 ± 1.2 6.1 ± 3.5 349.6 ± 12a 98.3%
aDenotes statistically significance difference by student t test at P < 0.05 compared to excretion rates of intact 125I-albumin and of albumin by RIA.
Table 2. Fractionation of rat urine containing 125 I-albumin fragmentation products by gel filtration chromatography
Fraction Fraction Fraction <5 kD
No. of animals Fraction > 60 kD 14 to 60 kD 5 to 14 kD (free 125I-iodine)
Percent of total radioactive material 4 4.5 ± 0.6 29.5 ± 4.7 65.9 ± 3.4 0.1 ± 0.003
Table 3. Excretion rates of intact and total 125I-albumin (intact + degraded) in ex-vivo rat kidneys perfused with 125I-albumin; degradation of
125I-albumin was inhibited by pretreatment of kidney with chloroquine
Excretion rate of
Excretion rate of total 125I-albumin Percent
intact 125I-albumin (intact and degraded) 125I-albumin
cpm/min cpm/min degraded in urine
Control (N = 10) 950 ± 228 9532 ± 2661 90.3%
Chloroquine pretreated (N = 4) 5467 ± 1031a 11,595 ± 3178 52.9%a
Data is presented as mean ± standard error.
aDenotes statistically significant difference compared to control by Student t test at P < 0.05.
were consistent with the high amount of albumin degra-
dation we observed by TCA precipitation analysis in the
previous experiments.
Excretion rate of 125I-albumin in the ex vivo kidney:
Effect of chloroquine pretreatment
The excretion rates of intact and total 125I-albumin
products in the urine were determined in the ex vivo per-
fused kidneys to rule out the possibility that 125I-albumin
was degraded in the circulation and that the degraded
products were excreted in the urine. The excretion rate
of total 125I-albumin (intact + degraded) in the ex vivo
perfused kidneys was 10 times higher than the rate of
excretion of intact 125I-albumin (Table 3), again showing
that 125I-albumin was largely present in a degraded form
in the urine and that the degradation process took place
in the kidney. Note that the difference in the excretion
rates between the intact and total albumin was not as
high as 70 times observed in vivo (Table 1) probably due
to the suboptimal physiologic condition of the ex vivo
preparation.
To test if the degradation of albumin was taking
place intracellularly in the lysosomal compartment of
the tubular cell, we measured 125I-albumin excretion in a
separate group of rats after pretreatment of the ex vivo
kidney preparation with chloroquine, a drug that inacti-
vates lysosomal enzymes by increasing the lysosomal pH.
The data in Table 2 showed that although chloroquine
treatment did not significantly change the excretion rate
of the total 125I-albumin excreted, it greatly increased the
excretion rate of intact 125I-albumin (sixfold) by inhibit-
ing the degradation of 125I-albumin (90.3% in control ver-
sus 52.9% in chloroquine-pretreated rat kidneys).
Binding and endocytosis of albumin by cultured human
proximal tubular cells (HK-2)
To further characterize the cellular binding and
degradation of albumin, we incubated HK-2 cells with
125I-albumin and followed its fate in the medium and
cell. Figure 2 shows the binding of 125I-albumin on HK-2
cells at 4◦C. The binding was saturable (Fig. 2A), and
inhibitable by unlabeled albumin (Fig. 2B), suggesting
the presence of a receptor on the cell. Scatchard analy-
sis of the data by Enzfitter software program (Elsevier-
Biosoft, Cambridge, UK) [14] yielded a KD of 1.25 mg/mL
and a Bmax of 1.22 lg/106 cells. When cells were incu-
bated with 125I-albumin at 37◦C, the cells endocytosed al-
bumin in a time-dependent manner with a steady-state
level reached in 4 hours (Fig. 3). Endocytosis of 125I-
albumin at 37◦C was also dependent on the concentra-
tion of 125I-albumin in the medium, reaching saturation
at ∼2.2 mg/mL (data not shown); it was inhibitable by un-
labeled albumin (data not shown) and at the saturating
concentration of 125I-albumin in the medium the steady-
state level of endocytosed albumin was 7.3 lg/106 cells.
The endocytosis of FITC-albumin (and its inhibition by
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Fig. 2. Binding characteristics. (A) Binding characteristics of 125I-
albumin on the cultured proximal tubular cell (HK-2). (B) Competitive
inhibition of 125I-albumin binding on HK-2 cells by increasing concen-
trations of unlabeled albumin (N = 6 at each point with the standard
error of mean shown by limit bars). 125I-albumin binding on the cell
reached saturation at ∼2.5 mg/mL of 125I-albumin in the media. Scar-
chard analysis of the data by Enzfitter software program yielded a KD
of 1.25 mg/mL and a Bmax of 1.22 ug albumin/106 cells.
unlabeled albumin) was visually demonstrated by fluo-
roscence microscopy (Fig. 4).
Processing of endocytosed albumin by the HK-2 cells
The fate of endocytosed albumin was studied to gain
further insight in the handling of albumin by the proximal
tubular cells. Following endocytosis of 125I-albumin there
was a time-dependent release of degraded and intact al-
bumin in the media (data not shown). Examination of the
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Fig. 3. Time-course of endocytosis of 125I-albumin at 37◦C by HK-
2 cells in presence of saturating concentration of 125I-albumin in the
media (10 mg/mL). The cells endocytosed 125I-albumin in a time-
dependent manner with a steady-state level of 7.3 lg albumin/106 cells
reached in 4 hours (N = 6 at each point with the standard error of mean
shown by limit bars).
media and the cell extract by gel filtration chromatogra-
phy and SDS-PAGE showed the presence of fragments
of albumin in both media and cell extracts (Figs. 5 and
6). The sizes of the fragments in the media were lower
than those present in the cells, suggesting that prior to
the release of fragments in the medium 125I-albumin was
progressively degraded inside the cell.
We investigated whether the degradation process took
place in the lysosomes by studying the degradation of en-
docytosed 125I-albumin in cells pretreated with chloro-
quine, which inactivates lysosomal enzymes. In cells
treated with chloroquine, the amount of degraded 125I-
albumin appearing in the medium was inhibited by 80%
showing that the lysosomal enzymes were responsible for
the degradation of 125I-albumin (Fig. 7). This effect could
not have been due to a reduced up-take of 125I-albumin
by chloroquine-treated cells as it was determined that
chloroquine pretreatment did not affect the uptake of
125I-albumin (data not shown).
Apical and basal excretion of 125I-albumin degradation
products by HK-2 cells
HK-2 cells grown on Millicell dishes were allowed
to endocytose 125I-albumin from the apical side.
Subsequently, the apical and basal compartments
were analyzed for intact and fragmented 125I-
albumin (Fig. 8). Of the total intact 125I-albumin
exocytosed, equal amounts appeared in the apical
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A B
Fig. 4. Endocytosis of fluorescein isothiocyanate (FITC)-albumin by HK-2 cells and its inhibition in the presence of unlabeled albumin. (A) Uptake
in presence of 2.5 mg/mL of FITC-albumin. (B) Uptake in presence 2.5 mg/mL FITC-albumin plus 1 mg/mL of unlabeled albumin. The competitive
inhibition of the binding of FITC-albumin was suggestive of the presence of an albumin binding receptor on the HK-2 cells (magnification 500×).
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14.5 kD
125I-albumin Extract Media
Fig. 5. Analysis of cell extract and media of HK-2 cells contain-
ing degradation products of 125I-albumin by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) followed by autora-
diography. Cells were allowed to endocytose 125I-albumin for 4 hours
after which the cell layer was washed with fresh media containing unla-
beled albumin to remove membrane-bound 125I-albumin and the cells
further incubated for 18 hours at 37◦C. Media showed several fragments
of 125I-albumin in the range of 14 to 66 kD, including intact 125I-albumin
(black arrows). Cell extracts also showed fragments of 125I-albumin,
though they were of higher sizes than those seen in the media.
and basal compartments. On the other hand,
exocytosed fragmented 125I-albumin was preferen-
tially excreted to the basal media (65%) and smaller
amounts to the apical media (35%).
DISCUSSION
The data presented in this paper indicate that normal
urine contains small amounts of intact albumin but much
larger quantities of low molecular peptides derived from
albumin. By studying the urinary excretion of systemi-
cally injected 125I-albumin we found that the excretion
of intact 125I-albumin was similar to that determined by
RIA, and that the total albumin excretion (intact + de-
graded) was 70 times higher than the amount of intact
albumin measured by RIA. These findings indicate that
98% to 99% of the excreted albumin in the urine was de-
graded and that only 1% to 2% was intact. It is notewor-
thy that most dye-binding and other immunoassays have
failed to detect the presence of these high levels of albu-
min fragments because they measure only intact albumin
and not its degradation products (unpublished findings).
In that regard, albumin measurements in urine with the
current assays, especially for the purpose of estimating
clearances will be grossly underestimated. For greater
accuracy such measurements should therefore take into
account the sum of albumin and its fragments.
We excluded the possibility that 125I-albumin was de-
graded systemically and excreted in the urine by demon-
strating that the labeled albumin in the serum was
99% TCA precipitable throughout the experimental pe-
riod. To further rule out this possibility, we performed
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Fig. 6. Gel filtration chromatography of HK-2 cell extract and media
containing degradation products of 125I-albumin. Arrows at the top
indicate the position of elution of the standard molecular-weight marker
proteins. Cells were allowed to endocytose 125I-albumin for 4 hours after
which the cell layer was washed with fresh media containing unlabeled
albumin to remove membrane-bound 125I-albumin and the cells further
incubated for 18 hours at 37◦C. Cell media showed intact 125I-albumin
and fragments of albumin including the smaller ones of less than 14 kD
size. Cell extracts showed a broad peak containing a mixture of intact
and large-sized fragments of 125I-albumin.
similar experiments by perfusing 125I-albumin in the iso-
lated ex vivo kidney preparation and studying the ex-
cretion of intact and degraded 125I-albumin. Such ex vivo
studies, which avoid the modifying effects of other organs
(especially the liver and blood vessels) on the circulating
125I-albumin, yielded a similar result that is the kidney
degraded most of the albumin present in the urine.
Our results appear contradictory to those of Park and
Maack [5], which failed to detect degradation products
in the apical side of the proximal tubule and thus implied
that fragments should not be present in the urine. The
results of these earlier studies, although clear, need to
be interpreted with caution because only small segments
of tubules (0.5 mm) were used. Further, the fragmenta-
tion of albumin was studied by the TCA precipitation
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Fig. 7. Degradation of endocytosed 125I-albumin by HK-2 cells in
presence of chloroquine. Cells were pretreated with chloroquine (10
lmol/L), then allowed to endocytose 125I-albumin for 4 hours after
which the cell layer was washed with fresh media containing unlabeled
albumin to remove membrane-bound 125I-albumin and the cells further
incubated for 18 hours at 37◦C. Media was collected and degradation
of 125I-albumin was tested by trichloroacetic acid (TCA) precipitation.
Pretreatment with chloroquine, which increases lysosomal pH, inhib-
ited the degradation of 125I-albumin by 80% (compared to control)
indicating that the lysosomal enzymes were responsible for the degra-
dation of 125I-albumin. This effect could not be due to a reduced up-
take of 125I-albumin by chloroquine-treated cells as it was determined
that chloroquine pretreatment did not affect the uptake of 125I-albumin
(data not shown) (N = 6 at each point with the standard error of mean
shown by limit bars). ∗Statistical significance at P < 0.05 compared to
control.
analyses and not by chromatography. The TCA analysis
is at best only a crude method to assess fragmentation,
because intermediate fragments are inconsistently pre-
cipitated by TCA, as we show in the present study (see
Results section). Thus, the complete degradation of reab-
sorbed albumin in the proximal tubule and the absence
of fragments in the urine in this model may simply re-
flect the limitations of the experimental design and the
imprecise method used to assess degradation.
Russo, Bakris, and Comper have suggested that the
kidney degraded albumin by demonstrating the presence
of tritiated substances in the urine following injection of
tritium-labeled albumin (reviewed in [16]). However, the
use of tritium-labeled albumin can confound the interpre-
tation because following the degradation of the albumin
by tubular cells, the resulting tritium-labeled amino acids
can be reincorporated into other proteins of the tubular
cell, thus spuriously underestimating the amounts of al-
bumin fragments measured in the urine and therefore of
the proportion of albumin degraded and also the total
albumin handled by the tubule. In several studies in the
rat [6, 17–19], these investigators showed that the total
Gudehithlu et al: Renal handling of albumin 2121
0
10
20
30
40
50
60
In
ta
ct
 12
5 I-
al
bu
m
in
,
%
 o
f t
ot
al
 in
ta
ct
Apical Basal
A
0
10
20
30
40
50
60
70
D
eg
ra
de
d 
12
5 I-
al
bu
m
in
,
%
 o
f t
ot
al
 d
eg
ra
de
d
Apical Basal
B
*
Fig. 8. Excretion of 125I-albumin and its degradation products to api-
cal and basal media after endocytosis. This was studied in cells grown in
Millicell dishes, which permitted access to both the apical and basal
fluid compartments of the cell. Cells were allowed to endocytose 125I-
albumin to reach steady-state levels after which membrane-bound al-
bumin was washed away with excess unlabeled albumin and cells were
then allowed to process the internalized 125I-albumin for 18 hours. The
media from the apical and basal compartments were analyzed for intact
and fragmented 125I-albumin by trichloroacetic acid (TCA) analysis.
Of the total intact 125I-albumin exocytosed, equal amounts appeared
in the apical and basal compartments (A). On the other hand, exocy-
tosed fragmented 125I-albumin was preferentially excreted to the basal
media (65%) and smaller amounts to the apical media (35%) (B) (N =
5 at each point with the standard error of mean shown by limit bars).
∗Statistical significance at P < 0.05 compared to basal in the same chart.
(intact + degraded) albumin excretion varied from 0.15
to 0.5 mg/100 g body weight/hour with 90% of the albu-
min present in the degraded form. In contrast, in our stud-
ies we found that the total albumin excretion was much
higher (6.5 mg/100 g body weight/hour) with >98% of
albumin present in the degraded form in the urine. The
reason for the lower estimate of the excreted albumin
by Osicka et al [6] may be related to the problems in-
herent in the use of tritium-labeled albumin. Our results
would suggest a very high turnover of albumin in the rat.
Consistent with this Keysen, Kirkpatrick, and Couser [20]
using 125I-albumin to study the catabolic rate of albumin
in normal rats in steady-state found that 5.7 mg/100 g
body weight/hour is catabolized through urine per day,
a value far higher than Comper’s estimate, but close to
the 6.5 mg/100 g body weight/hour we determined in our
experiments.
Because more detailed studies on the uptake and
metabolic handling of albumin by the proximal tubule
cannot be done in in vivo or in ex vivo kidney prepara-
tions, we carried out additional studies were conducted in
a well-characterized HK-2 cell line derived from the hu-
man proximal tubule (for the sake of consistency these
studies should ideally have been performed in a rat prox-
imal tubular cell line, but such a cell line is not available).
We observed that HK-2 cells have an active receptor that
binds and internalizes albumin. We also determined that
the affinity constant (KD) of albumin binding in the HK-
2 cells was 1.25 mg/mL, a value very close to the KD of
1.2 mg/mL determined for the predominant low affinity,
high capacity receptor present in vivo in the proximal
tubule [5]. Most previous work on the details of albumin
handling was done in the opossum proximal tubular cells,
which showed that albumin was taken up by a receptor
complex consisting of megalin and cubulin and that the
degradation products were released into the apical side
[15, 21, 22]. These studies, however, did not characterize
the size of the fragments, nor did their experimental set-
up allow the sampling of the basolateral side to determine
if the albumin degradation products were also released to
the other side of the cell. We found that HK-2 cells inter-
nalized albumin and processed it in the lysosomal system
to produce fragments, some of which were exocytosed to
the medium. The degraded albumin was excreted mainly
at the basal side, but some was excreted at the apical loca-
tion, consistent with our experiments in rats where signif-
icant amounts of degraded albumin were detected in the
urine. However, the proportions derived from our exper-
iments, of the intact and degraded albumin excreted to
the apical/basal sides in normal conditions, may not hold
true in proteinuric states.
Using a combination of in vivo, ex vivo kidney, and
proximal tubule cell models, we have shown that albu-
min is rapidly and extensively degraded by the proximal
tubule cell. More importantly, a large portion of the de-
graded products is lost in the urine as peptides, and the re-
maining portion reabsorbed. These findings are in sharp
contrast with the established view that degraded albumin
is completely reabsorbed into the blood stream.
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